Capricor Therapeutics reported $2.56M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Bluebird Bio BLUE:US USD 33.4M 3.29M
Capricor Therapeutics CAPR:US USD 2.56M 208.29K
Cytokinetics CYTK:US USD 48.22M 5.51M
Cytori Therapeutics CYTX:US USD 2.22M 67K
Geron GERN:US USD 15.64M 8.2M
Johnson & Johnson JNJ:US USD 6.09B 137M
Newlink Genetics NLNK:US USD 3.92M 236K
Prothena PRTA:US USD 11.99M 963K
Ptc Therapeutics PTCT:US USD 80.12M 226K
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Vital Therapies VTL:US USD 3.58M 493K